azasetron has been researched along with Acoustic Trauma in 1 studies
azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;
Acoustic Trauma: Usually refer to hearing loss due to a single noise event such as an explosion or shotgun blast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "SENS-401 (R-azasetron besylate) is effective against severe acoustic trauma-induced hearing loss." | 3.91 | SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours. ( Broussy, A; Dyhrfjeld-Johnsen, J; Petremann, M; Poli, S; Romanet, C; Van Ba, CT, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petremann, M | 1 |
| Romanet, C | 1 |
| Broussy, A | 1 |
| Van Ba, CT | 1 |
| Poli, S | 1 |
| Dyhrfjeld-Johnsen, J | 1 |
1 other study available for azasetron and Acoustic Trauma
| Article | Year |
|---|---|
SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours.
Topics: Acoustic Stimulation; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Evoked Potentials | 2019 |